Titlebook: Assessing the Economic Value of Anticancer Therapies; Niels Neymark Conference proceedings 1998 Springer-Verlag Berlin · Heidelberg 1998 K

condemn

Food web complexity II: empirical results,ms very concise and useful, stressing that such care should not be restricted to patients with malignant disease and that terminal care is only one aspect of palliative care, albeit a very important one. The concept embraces optimal symptom control and quality of life as well as appropriate rehabilitation.

considerable

miracle

scotoma

SpringerBriefs in Environmental Sciencehealth care services), which is increasingly often faced with the need to document the economic value for money of new products. Not surprisingly, then, health economics is very often perceived as identical to one of its (important) subdisciplines, economic evaluation, which was very recently dubbed pharmacoeconomics, for obvious reasons.

Dorsal

engrossed

Gabriella Dellino,Renato Mari,Carlo Meloni one tenth of the patients discharged from hospitals have cancer as their primary diagnosis, while the direct medical costs of cancer treatment and care are comparatively low. Most studies show that the share of cancer-related health care services in the yearly direct medical costs borne by the countries concerned is in the order of 5%–7%.

overbearing

精美食品

Walter Leal Filho,Marina Kovaleva understanding of the later chapters, in which the published economic evaluations will be reviewed and discussed in the light of short descriptions of the most important clinical issues concerning the various cancer sites.

季雨

抱怨

Models and their local stability,gimens, is their myeloablative and immunosuppressive effect, making the patients susceptible to infections by many different microorganisms. If there is a positive dose-response relationship for the treatment concerned, this factor may also have a serious impact on the treatment results obtainable.